ArticlePharmaceuticals (Basel, Switzerland)2023

Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study.

Danielle Delombaerde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.